Antineoplastic AgentsRadiation DosageRadiation, IonizingRadiation InjuriesDose-Response Relationship, RadiationRadiation ToleranceCell Line, TumorRadiationNeoplasmsDrug Screening Assays, AntitumorRadiation ProtectionRadiation MonitoringApoptosisMosaicismCell SurvivalChromosome AberrationsDoxorubicinCell ProliferationKaryotypingDrug Resistance, NeoplasmCell DivisionRadiation OncologyCell CycleMutationAntineoplastic Agents, PhytogenicCisplatinAntibiotics, AntineoplasticCosmic RadiationDrug Delivery SystemsRadiation Injuries, ExperimentalGamma RaysChromosome DisordersIn Situ Hybridization, FluorescenceTumor Cells, CulturedRadiation PneumonitisDrug CarriersSignal TransductionDNA DamageXenograft Model Antitumor AssaysMice, NudeTumor Suppressor Protein p53Neoplasms, Radiation-InducedRadiation-Sensitizing AgentsRadiotherapyBackground RadiationEllipticinesUterine Cervical NeoplasmsMolecular Sequence DataCells, CulturedTime FactorsUltraviolet RaysModels, BiologicalCytodiagnosisFlow CytometryPhenotypeMitosisCell LineEtoposideCamptothecinPaclitaxelCombined Modality TherapyRadiometryBone MarrowRadiotherapy DosageVaginal SmearsAneuploidyDrug Resistance, MultipleInhibitory Concentration 50Cell Cycle ProteinsCell Transformation, NeoplasticP-GlycoproteinRadiation EffectsMolecular StructureBlotting, WesternDose-Response Relationship, DrugCell NucleusImmunohistochemistryDrug DesignBreast NeoplasmsDNA-Binding ProteinsFibroblastsDrug SynergismRadiation-Protective AgentsCell WallBase SequenceDNA Topoisomerases, Type IIStaining and LabelingProdrugsPhosphorylationDNA RepairRNA, MessengerCell DifferentiationCell MovementEnzyme InhibitorsLymphocytesFluorouracilAcute Radiation SyndromeTopoisomerase I InhibitorsGene Expression Regulation, NeoplasticAmino Acid Sequence